Zaoqu Liu

6.1k total citations · 5 hit papers
142 papers, 3.4k citations indexed

About

Zaoqu Liu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Zaoqu Liu has authored 142 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 61 papers in Pulmonary and Respiratory Medicine and 48 papers in Molecular Biology. Recurrent topics in Zaoqu Liu's work include Ferroptosis and cancer prognosis (47 papers), Cancer Immunotherapy and Biomarkers (43 papers) and Immune cells in cancer (23 papers). Zaoqu Liu is often cited by papers focused on Ferroptosis and cancer prognosis (47 papers), Cancer Immunotherapy and Biomarkers (43 papers) and Immune cells in cancer (23 papers). Zaoqu Liu collaborates with scholars based in China, United Kingdom and United States. Zaoqu Liu's co-authors include Xinwei Han, Quan Cheng, Peng Luo, Libo Wang, Long Liu, Jian Zhang, Siyuan Weng, Yuyuan Zhang, Qin Dang and Chunguang Guo and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Zaoqu Liu

137 papers receiving 3.4k citations

Hit Papers

Machine learning-based integration develops an immune-der... 2022 2026 2023 2024 2022 2023 2022 2025 2024 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
    2022 455 citations Zaoqu Liu, Long Liu et al. profile →
  2. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
    2023 228 citations Hao Zhang, Zaoqu Liu et al. profile →
  3. Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
    2022 174 citations Hao Zhang, Zeyu Wang et al. profile →
  4. Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
    2025 77 citations Fan Guan, Ruixuan Wang et al. Signal Transduction and Targeted Therapy profile →
  5. Multi-stage mechanisms of tumor metastasis and therapeutic strategies
    2024 54 citations Zaoqu Liu, Jingqi Chen et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zaoqu Liu China 32 1.5k 1.2k 1.2k 1.1k 826 142 3.4k
Andreas Pircher Austria 27 1.7k 1.1× 855 0.7× 1.5k 1.2× 931 0.9× 871 1.1× 103 3.4k
Sigve Andersen Norway 33 1.6k 1.1× 1.2k 1.0× 2.0k 1.6× 1.4k 1.3× 981 1.2× 80 3.9k
Shunchang Jiao China 30 1.1k 0.8× 977 0.8× 1.9k 1.5× 655 0.6× 618 0.7× 144 3.4k
Ernest Nadal Spain 34 1.5k 1.0× 1.8k 1.5× 1.8k 1.5× 815 0.8× 361 0.4× 169 3.6k
Samer Al‐Saad Norway 36 1.7k 1.2× 1.2k 0.9× 2.3k 1.9× 1.3k 1.2× 1.3k 1.5× 66 4.3k
Theodoros Foukakis Sweden 33 1.4k 1.0× 726 0.6× 2.1k 1.7× 1.5k 1.4× 719 0.9× 135 4.1k
Tomomi Kamba Japan 27 1.3k 0.9× 1.2k 1.0× 1.0k 0.8× 635 0.6× 292 0.4× 152 3.3k
Biagio Ricciuti United States 33 1.1k 0.7× 1.7k 1.3× 2.6k 2.1× 774 0.7× 481 0.6× 161 3.8k
Fei Zhou China 31 885 0.6× 1.7k 1.4× 1.9k 1.6× 597 0.6× 376 0.5× 122 3.3k
Rafael Santana-Dávila United States 22 1.7k 1.1× 1.2k 0.9× 1.7k 1.4× 671 0.6× 283 0.3× 70 3.7k

Countries citing papers authored by Zaoqu Liu

Since Specialization
Citations

This map shows the geographic impact of Zaoqu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zaoqu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zaoqu Liu more than expected).

Fields of papers citing papers by Zaoqu Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zaoqu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zaoqu Liu. The network helps show where Zaoqu Liu may publish in the future.

Co-authorship network of co-authors of Zaoqu Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zaoqu Liu. A scholar is included among the top collaborators of Zaoqu Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zaoqu Liu. Zaoqu Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Yuqing, Congying Yuan, Yuhao Ba, et al.. (2025). 3D Bioprinting for Engineering Organoids and Organ‐on‐a‐Chip: Developments and Applications. Medicinal Research Reviews. 45(6). 1630–1650. 5 indexed citations
2.
Guan, Fan, Ruixuan Wang, Peng Luo, et al.. (2025). Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets. Signal Transduction and Targeted Therapy. 10(1). 93–93. 77 indexed citations breakdown →
3.
Ren, Yuqing, Yi Yue, Xinyang Li, et al.. (2024). Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy. International Immunopharmacology. 142(Pt A). 113147–113147. 7 indexed citations
4.
Li, Haitao, Cangang Zhang, Zaoqu Liu, et al.. (2024). Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity. Clinical and Translational Medicine. 14(3). e1620–e1620. 10 indexed citations
5.
Zhou, Zhaokai, Yifeng Chen, Yuhao Ba, et al.. (2024). Revolutionising Cancer Immunotherapy: Advancements and Prospects in Non‐Viral CAR‐NK Cell Engineering. Cell Proliferation. 58(4). e13791–e13791. 10 indexed citations
6.
Yang, Hong, Anqi Lin, Zaoqu Liu, et al.. (2024). PESSA: A web tool for pathway enrichment score-based survival analysis in cancer. PLoS Computational Biology. 20(5). e1012024–e1012024. 2 indexed citations
7.
Liu, Zaoqu, Jingqi Chen, Yuqing Ren, et al.. (2024). Multi-stage mechanisms of tumor metastasis and therapeutic strategies. Signal Transduction and Targeted Therapy. 9(1). 270–270. 54 indexed citations breakdown →
8.
Liu, Zaoqu, Zhaokai Zhou, Yuhao Ba, et al.. (2024). Targeting immunosenescence for improved tumor immunotherapy. SHILAP Revista de lepidopterología. 5(11). e777–e777. 13 indexed citations
9.
Chen, Zhuang, Yuhao Ba, Qin Dang, et al.. (2023). MPDZ is associated with immune infiltration and regulates migration and invasion by switching YAP1 phosphorylation in colorectal cancer. Cellular Signalling. 114. 110967–110967. 3 indexed citations
10.
Liu, Long, Yuhui Wang, Yuyuan Zhang, et al.. (2023). Gene expression profiles contribute to robustly predicting prognosis in hepatocellular carcinoma. Genes & Diseases. 11(2). 593–596. 2 indexed citations
11.
Liu, Zaoqu, et al.. (2023). Associations Between Life's Essential 8 and Abdominal Aortic Calcification Among Middle‐Aged and Elderly Populations. Journal of the American Heart Association. 12(24). e031146–e031146. 19 indexed citations
12.
Lin, Anqi, Ting Wei, Mengyao Li, et al.. (2022). CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer. Briefings in Bioinformatics. 23(3). 88 indexed citations
13.
Wang, Zicheng, Xisong Liang, Hao Zhang, et al.. (2022). Identification of a Hypoxia-Angiogenesis lncRNA Signature Participating in Immunosuppression in Gastric Cancer. Journal of Immunology Research. 2022. 1–24.
14.
Xu, Hui, Zaoqu Liu, Siyuan Weng, et al.. (2022). Artificial intelligence‐driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi‐center integration analysis. Molecular Oncology. 16(22). 4023–4042. 21 indexed citations
15.
16.
Liu, Zaoqu, Dechao Jiao, Long Liu, et al.. (2021). Development and validation of a robust immune-related risk signature for hepatocellular carcinoma. Medicine. 100(10). e24683–e24683. 8 indexed citations
17.
Zhou, Xueliang, Mengmeng Dou, Zaoqu Liu, et al.. (2021). Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma. Journal of Immunology Research. 2021. 1–20. 8 indexed citations
18.
Liu, Zaoqu, Long Liu, Taoyuan Lu, et al.. (2021). Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management. Journal of Oncology. 2021. 1–20. 27 indexed citations
19.
Yao, Yuan, Zhaonan Li, Xueliang Zhou, et al.. (2021). Roles of Bile‐Derived Exosomes in Hepatobiliary Disease. BioMed Research International. 2021(1). 8743409–8743409. 9 indexed citations
20.
Yao, Yuan, Zaoqu Liu, Jianjian Chen, et al.. (2020). Novel miRNA Predicts Survival and Prognosis of Cholangiocarcinoma Based on RNA‐seq Data and In Vitro Experiments. BioMed Research International. 2020(1). 5976127–5976127. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Pircher Breakdown of academic impact, for papers by Sigve Andersen Breakdown of academic impact, for papers by Shunchang Jiao Breakdown of academic impact, for papers by Ernest Nadal Breakdown of academic impact, for papers by Samer Al‐Saad Breakdown of academic impact, for papers by Theodoros Foukakis Breakdown of academic impact, for papers by Tomomi Kamba Breakdown of academic impact, for papers by Biagio Ricciuti Breakdown of academic impact, for papers by Fei Zhou Breakdown of academic impact, for papers by Rafael Santana-Dávila
Rankless by CCL
2026